eISSN: 2449-8580
ISSN: 1734-3402
Family Medicine & Primary Care Review
Current issue Archive Manuscripts accepted About the journal Editorial board Reviewers Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
Search
4/2023
vol. 25
 
Share:
Send email
Share:
Original paper

Effects of delay in visiting a specialist doctor in type 2 diabetic patients on glycemic control: a retrospective cohort study with a 4-year follow-up

Mohadeseh Ghanbari-Jahromi
1
,
Erfan Kharazmi
2
,
Peivand Bastani
3
,
Mesbah Shams
4
,
Mohammad Aryaie
5
,
Mohammad Amin Bahrami
2

1.
Student Research Committee, Shiraz University of Medical Sciences, Shiraz, Iran
2.
Health Human Resources Research Centre, School of Health Management and Information Sciences, Shiraz University of Medical Sciences, Shiraz, Iran
3.
College of Health and Human Sciences, Faculty of Health, Charles Darwin University, Darwin, Australia
4.
Endocrinology and Metabolism Research Centre, Shiraz University of Medical Sciences, Shiraz, Iran
5.
School of Public Health, Imperial College London, London, United Kingdom
Family Medicine & Primary Care Review 2023; 25(4): 393–398
DOI: https://doi.org/10.5114/fmpcr.2023.132612
Online publish date: 2023/12/27
Article file
- 03 FM&PCR 4 23 - O - Ghanbari-Jahromi - 1326 - Effects.pdf  [0.51 MB]
Get citation
 
PlumX metrics:
 
1. American Diabetes Association. Economic costs of diabetes in the U.S. In 2007. Diabetes Care 2008; 31: 596–615.
2. Afroz A, Alramadan MJ, Hossain MN, et al. Cost-of-illness of type 2 diabetes mellitus in low and lower-middle income countries: a systematic review. BMC Health Serv Res 2018; 18(1): 972, doi: 10.1186/s12913-018-3772-8.
3. Anjana RM, Pradeepa R, Deepa M, et al. Acceptability and utilization of newer technologies and effects on glycemic control in type 2 diabetes: lessons learned from lockdown. Diabetes Technol Ther 2020; 22(7): 527–534, doi: 10.1089/dia.2020.0240.
4. Shaw JE, Sicree RA, Zimmet PZ. Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res Clin Pract 2010; 87(1): 4–14, doi: 10.1016/j.diabres.2009.10.007.
5. Peric S, Stulnig TM. COVID-19: disease-management-people. Wien Klin Wochenschr 2020; 132(13–14): 356–361, doi: 10.1007/s00508-020-1672-3.
6. National Institute of Health and Nutrition. Health Japan 21 (the second term) (cited 21.02.2023). Available from URL: https://www.nibiohn.go.jp/eiken/kenkounippon21/en/index.html.
7. Paul SK, Klein K, Thorsted BL, et al. Delay in treatment intensification increases the risks of cardiovascular events in patients with type 2 diabetes. Cardiovasc Diabetol 2015; 14(100), doi: 10.1186/s12933-015-0260-x.
8. Mendenhall E, Musau A, Bosire E, et al. What drives distress? Rethinking the roles of emotion and diagnosis among people with diabetes in Nairobi, Kenya. Anthropol Med 2020; 27(3): 252–267, doi: 10.1080/13648470.2019.1650243.
9. Gavan NA, Veresiu IA, Vinik EJ, et al. Delay between onset of symptoms and seeking physician intervention increases risk of diabetic foot complications: results of a cross-sectional population-based survey. J Diabetes Res 2016; 2016: 1567405, doi: 10.1155/2016/.
10. Islam SMS, Uddin R, Zaman SB, et al. Healthcare seeking behavior and glycemic control in patients with type 2 diabetes attending a tertiary hospital. Int J Diabetes Dev Ctries 2021; 41(2): 280–287, doi: 10.1007/s13410-020-00875-8.
11. Islam SMS, Lechner A, Ferrari U, et al. Healthcare use and expenditure for diabetes in Bangladesh. BMJ Glob Health 2017; 2(1): e000033, doi: 10.1136/bmjgh-2016-.
12. Gostin LO, Wiley LF. Governmental public health powers during the COVID-19 pandemic: stay-at-home orders, business closures, and travel restrictions. JAMA 2020; 323(21): 2137–2138, doi: 10.1001/jama.2020.5460.
13. Banerjee M, Chakraborty S, Pal R. Diabetes self-management amid COVID-19 pandemic. Diabetes Metab Syndr 2020; 14(4): 351–354, doi: 10.1016/j.dsx.2020.04.013.
14. Vamos EP, Khunti K. Indirect effects of the COVID-19 pandemic on people with type 2 diabetes: time to urgently move into a recovery phase. BMJ Quality & Safety 2022; 31(7): 483–485, doi: 10.1136/bmjqs-2021-014079.
15. Barone MTU, Harnik SB, de Luca PV, et al. The impact of COVID-19 on people with diabetes in Brazil. Diabetes Res Clin Pract 2020; 166: 108304, doi: 10.1016/j.diabres.2020.
16. Biamonte E, Pegoraro F, Carrone F, et al. Weight change and glycemic control in type 2 diabetes patients during COVID-19 pandemic: the lockdown effect. Endocrine 2021; 72(3): 604–610, doi: 10.1007/s12020-021-02739-5.
17. Coma E, Miró Q, Medina M, et al. Association between the reduction of face-to-face appointments and the control of patients with type 2 diabetes mellitus during the COVID-19 pandemic in Catalonia. Diabetes Res Clin Pract 2021; 182: 109127, doi: 10.1016/j.diabres.2021.
18. Falcetta P, Aragona M, Ciccarone A, et al. Impact of COVID-19 lockdown on glucose control of elderly people with type 2 diabetes in Italy. Diabetes Res Clin Pract 2021; 174: 108750, doi: 10.1016/j.diabres.2021.
19. Chudasama YV, Gillies CL, Zaccardi F, et al. Impact of COVID-19 on routine care for chronic diseases: a global survey of views from healthcare professionals. Diabetes Metab Syndr 2020; 14(5): 965–967, doi: 10.1016/j.dsx.2020.06.042.
20. Joensen L, Madsen K, Holm L, et al. Diabetes and COVID-19: psychosocial consequences of the COVID-19 pandemic in people with diabetes in Denmark – what characterizes people with high levels of COVID-19 – related worries? Diabet Med 2020; 37(7): 1146–1154, doi: 10.11/dme.14319.
21. Fisher L, Polonsky W, Asuni A, et al. The early impact of the COVID-19 pandemic on adults with type 1 or type 2 diabetes: A national cohort study. J Diabetes Complications 2020; 34(12): 107748, doi: 10.1016/j.jdiacomp.2020.
22. Abidi A, Demiraj F, Berdichevskiy G, et al. The Effects of COVID-19 on Physicians’ Perceived Ability to Provide Care for Patients With Type II Diabetes Mellitus. Cureus 2022; 14(9): e29135, doi: 10.7759/cureus.
23. Moin JS, Troke N, Plumptre L, et al. The Impact of the COVID-19 Pandemic on Diabetes Care for Adults with Type 2 Diabetes in Ontario, Canada. Can J Diabe-tes 2022; 46(7): 715–721, doi: 10.1016/j.jcjd.2022.04.009.
24. Beran D, Perone SA, Perolini MC, et al. Beyond the virus: Ensuring continuity of care for people with diabetes during COVID-19. Prim Care Diabetes 2021; 15(1): 16–17, doi: 10.1016/j.pcd.2020.05.014.
25. Caballero A, Ceriello A, Misra A, et al. COVID-19 in people living with diabetes: an international consensus. J Diabetes Complications 2020; 34(9): 107671, doi: 10.1016/j.jdiacomp.2020.
26. Hartmann-Boyce J, Morris E, Goyder C, et al. Diabetes and COVID-19: risks, management, and learnings from other national disasters. Diabetes Care 2020; 43(8): 1695–1703, doi: 10.2337/dc20-1192.
27. Wicaksana AL, Hertanti NS, Ferdiana A, et al. Diabetes management and specific considerations for patients with diabetes during coronavirus diseases pan-demic: a scoping review. Diabetes Metab Syndr 2020; 14(5): 1109–1120, doi: 10.016/j.dsx.2020.06.070.
28. Sun C-A, Perrin N, Maruthur N, et al. Predictors of Follow-Up Appointment No-Shows Before and During COVID Among Adults with Type 2 Diabetes. Telemed J E Health 2023; 29(6): 851–865, doi: 10.1089/tmj.2022.0377.
29. Biancalana E, Parolini F, Mengozzi A, et al. Short-term impact of COVID-19 lockdown on metabolic control of patients with well-controlled type 2 diabetes: a single-centre observational study. Acta Diabetol 2021; 58(4): 431–436, doi: 10.1007/s00592-020-1637-y.
30. Ludwig L, Scheyer N, Remen T, et al. The impact of COVID-19 lockdown on metabolic control and access to healthcare in people with diabetes: the CONFI-DIAB cross-sectional study. Diabetes Ther 2021; 12(8): 2207–2021, doi: 10.1007/s13300-021-01105-y.
31. Park S-D, Kim S-W, Moon JS, et al. Impact of social distancing due to coronavirus disease 2019 on the changes in glycosylated hemoglobin level in people with type 2 diabetes mellitus. Diabetes Metab J 2021; 45(1): 109–114, doi: 10.4093/dmj.2020.0226.
32. Ghosal S, Sinha B, Majumder M, et al. Estimation of effects of nationwide lockdown for containing coronavirus infection on worsening of glycosylated haemoglobin and increase in diabetes-related complications: a simulation model using multivariate regression analysis. Diabetes Metab Syndr 2020; 14(4): 319–323, doi: 10.1016/j.dsx.2020.03.014.
33. Ruiz-Roso MB, Knott-Torcal C, Matilla-Escalante DC, et al. COVID-19 lockdown and changes of the dietary pattern and physical activity habits in a cohort of patients with type 2 diabetes mellitus. Nutrients 2020; 12(8): 2327, doi: 10.3390/nu12082327.
34. Proper K, Cerin E, Brown W, et al. Sitting time and socio-economic differences in overweight and obesity. Int J Obes (London) 2007; 31(1): 169–176, doi: 10.1038/sj.ijo.0803357.
35. Enguix DM, Cambronero MS, Rodríguez JCA, et al. Impact of COVID-19 on glycaemic control in a Spanish cohort of patients with type 2 diabetes. Practical Diabetes 2022; 39(1): 7–11, doi: 10.1002/pdi.2373.
36. Önmez A, Gamsızkan Z, Özdemir Ş, et al. The effect of COVID-19 lockdown on glycemic control in patients with type 2 diabetes mellitus in Turkey. Diabetes Metab Syndr 2020; 14(6): 1963–1966, doi: 10.016/j.dsx.2020.10.007.
37. Sankar P, Ahmed WN, Koshy VM, et al. Effects of COVID-19 lockdown on type 2 diabetes, lifestyle and psychosocial health: a hospital-based cross-sectional survey from South India. Diabetes Metab Syndr 2020; 14(6): 1815–1819, doi: 10.016/j.dsx.2020.09.005.
38. Tannus L, Zapelini R, Cabizuca C, et al. Effect of the COVID-19 pandemic on glycemic control in Brazilian patients with type 2 diabetes. Endocrine 2022; 77(3): 455–460, doi: 10.1007/s12020-022-03137-1.
39. Khare J, Jindal S. Observational study on Effect of Lock Down due to COVID 19 on glycemic control in patients with Diabetes: Experience from Central India. Diabetes Metab Syndr 2020; 14(6): 1571–1574, doi: 10.016/j.dsx.2020.08.012.
40. Oli J, Pant VP, Niraula A, et al. Poor Glycemic Control in Type 2 Diabetes Mellitus Patients in Two Tertiary Care Centers during COVID-19 Lockdown: A Descriptive Cross-sectional Study. JNMA J Nepal Med Assoc 2022; 60(247): 268–273, doi: 10.31729/jnma.6998.
41. Ghesquière L, Garabedian C, Drumez E, et al. Effects of COVID-19 pandemic lockdown on gestational diabetes mellitus: a retrospective study. Diabetes Metab 2021; 47(2): 101201, doi: 10.1016/j.diabet.2020.09.008.
42. Rastogi A, Hiteshi P, Bhansali A. Improved glycemic control amongst people with long-standing diabetes during COVID-19 lockdown: a prospective, observational, nested cohort study. Int J Diabetes Dev Ctries 2020; 40(4): 476–481, doi: 10.1007/s13410-020-00880-x.
43. Peimani M, Bandarian F, Namazi N, et al. COVID-19-specific worries among people with type 2 diabetes following the continuation of the pandemic and occurrence of multiple waves of COVID-19 in Iran. J Diabetes Metab Disord 2022; 21(1): 618, doi: 10.1007/s40200-021-00935-8.
Copyright: © 2023 Family Medicine & Primary Care Review. This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License (http://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
  
Termedia
About us Contact
Copyright notice Privacy policy Advertising policy Contact us
Quick links
Journals Books eBooks Events
© 2024 Termedia Sp. z o.o.
Developed by Bentus.